摘要
随着自身免疫病研究的不断深入与补充,相关标志物在临床预警、疾病诊断、伴随诊断、治疗评估、预后判断中发挥重要作用。神经系统自身免疫性疾病指标,自身免疫病新型自身抗体、特种蛋白及淋巴细胞亚群,生殖免疫自身抗体等生物标志物亟需实现从实验室研究向临床精准诊疗的转化。
As the research on autoimmune diseases has been more developed and supplemented,the related markers started to play an important role in clinical prediction,disease diagnosis,concomitant diagnosis,treatment evaluation,and prognosis determination.Biomarkers such as neurological autoimmune disease indicators,special proteins,lymphocyte subpopulation,reproduction related autoantibodies are in urgent need of translation from laboratory studies to clinical precise diagnosis and treatment.
作者
李永哲
Li Yongzhe(Department of Clinical Laboratory,Peking Union Medical College Hospital,Peking Union Medical College and Chinese Academy of Medical Science,Beijing 100730,China)
出处
《中华检验医学杂志》
CAS
CSCD
北大核心
2022年第9期881-885,共5页
Chinese Journal of Laboratory Medicine
基金
国家重点研发计划(2018YFE0207300)
国家自然科学基金(81871302)。
关键词
自身免疫疾病
诊断
生物标志物
伴随诊断
Autoimmune diseases
Diagnosis
Biomarkers
Companion diagnostics